Correlation Between Visa and Rossari Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Rossari Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Rossari Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Rossari Biotech Limited, you can compare the effects of market volatilities on Visa and Rossari Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Rossari Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Rossari Biotech.

Diversification Opportunities for Visa and Rossari Biotech

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Visa and Rossari is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Rossari Biotech Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rossari Biotech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Rossari Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rossari Biotech has no effect on the direction of Visa i.e., Visa and Rossari Biotech go up and down completely randomly.

Pair Corralation between Visa and Rossari Biotech

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.65 times more return on investment than Rossari Biotech. However, Visa Class A is 1.53 times less risky than Rossari Biotech. It trades about 0.13 of its potential returns per unit of risk. Rossari Biotech Limited is currently generating about -0.02 per unit of risk. If you would invest  26,221  in Visa Class A on September 29, 2024 and sell it today you would earn a total of  5,645  from holding Visa Class A or generate 21.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.21%
ValuesDaily Returns

Visa Class A  vs.  Rossari Biotech Limited

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Rossari Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rossari Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Visa and Rossari Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Rossari Biotech

The main advantage of trading using opposite Visa and Rossari Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Rossari Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will offset losses from the drop in Rossari Biotech's long position.
The idea behind Visa Class A and Rossari Biotech Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas